Cipla Ltd.
Healthcare
Cipla eyes fresh push into China
Indian pharmaceuticals giant Cipla Ltd that has scaled down its business in China over the last three-four years even as ......
Healthcare
Cipla BioTec hires banker for biggest PE fundraise in biosimilar space
Cipla BioTec Pvt Ltd, the bio-similar firm incubated by pharmaceuticals giant Cipla Ltd to develop anti-cancer drugs, has initiated the ......
Healthcare
Cipla names Umang Vohra global CEO, Samina Vaziralli vice chairman
Drugmaker Cipla Ltd on Friday named Umang Vohra its new managing director and global CEO and elevated promoter group scion ......
Healthcare
Cipla, Aurobindo Pharma to acquire drugs from Teva
Cipla Ltd and Aurobindo Pharma Ltd have agreed to acquire some generic drugs from Teva Pharmaceutical Industries Ltd in the ......
Healthcare
Cipla hires Kedar Upadhye from Dr Reddy's Labs as global CFO
Mumbai-based drugmaker Cipla Ltd said on Wednesday it has appointed Kedar Upadhye, a top executive from Dr Reddy's Laboratories Ltd, ......
Healthcare
Cipla invests $3M more in Chase Pharmaceuticals
Drugmaker Cipla Ltd said on Wednesday unit Cipla UK has invested $3 million (Rs 20 crore) more in Chase Pharmaceuticals ......
Healthcare
Eight Roads gets nod to invest in Cipla's consumer healthcare unit
Cipla Ltd has received regulatory nod to raise private equity funding from Eight Roads Ventures (formerly Fidelity Growth Partners India) ......
Healthcare
Cipla elevates Umang Vohra as COO; promoter scion to head M&A, VC unit
Mumbai-based drugmaker Cipla Ltd on Thursday expanded the role of promoter group scion Samina Vaziralli and appointed a new global ......
Healthcare
Cipla's PE deal with Eight Roads for consumer healthcare unit hits roadblock
Mumbai-based drugmaker Cipla Ltd's proposed deal to raise private equity funding from Eight Roads Ventures (formerly Fidelity Growth Partners India) ......
Healthcare
Cipla to sell 25% stake in Hong Kong-based biosimilars JV Biomab
Mumbai-based drugmaker Cipla Ltd has agreed to divest its entire 25 per cent equity stake in Hong Kong-based biosmilar drug ......
